160 related articles for article (PubMed ID: 16252305)
1. Differential detection of S100A8 in transitional cell carcinoma of the bladder by pair wise tissue proteomic and immunohistochemical analysis.
Tolson JP; Flad T; Gnau V; Dihazi H; Hennenlotter J; Beck A; Mueller GA; Kuczyk M; Mueller CA
Proteomics; 2006 Jan; 6(2):697-708. PubMed ID: 16252305
[TBL] [Abstract][Full Text] [Related]
2. Search for the tumor-related proteins of transition cell carcinoma in Taiwan by proteomic analysis.
Sheng KH; Yao YC; Chuang SS; Wu H; Wu TF
Proteomics; 2006 Feb; 6(3):1058-65. PubMed ID: 16400682
[TBL] [Abstract][Full Text] [Related]
3. Stage-dependent increase of orosomucoid and zinc-alpha2-glycoprotein in urinary bladder cancer.
Irmak S; Tilki D; Heukeshoven J; Oliveira-Ferrer L; Friedrich M; Huland H; Ergün S
Proteomics; 2005 Nov; 5(16):4296-304. PubMed ID: 16196100
[TBL] [Abstract][Full Text] [Related]
4. A strategy for high-resolution protein identification in surface-enhanced laser desorption/ionization mass spectrometry: calgranulin A and chaperonin 10 as protein markers for endometrial carcinoma.
Guo J; Yang EC; Desouza L; Diehl G; Rodrigues MJ; Romaschin AD; Colgan TJ; Siu KW
Proteomics; 2005 May; 5(7):1953-66. PubMed ID: 15816004
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous proteomic and genomic analysis of primary Ta urothelial cell carcinomas for the prediction of tumor recurrence.
Schultz IJ; De Kok JB; Witjes JA; Babjuk M; Willems JL; Wester K; Swinkels DW; Tjalsma H
Anticancer Res; 2007; 27(2):1051-8. PubMed ID: 17465243
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of cell cycle biomarkers in nonmuscle invasive bladder transitional cell carcinoma.
Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y
J Urol; 2007 Feb; 177(2):481-7; discussion 487. PubMed ID: 17222615
[TBL] [Abstract][Full Text] [Related]
7. High expression of cathepsin B in transitional bladder carcinoma correlates with tumor invasion.
Eiján AM; Sandes EO; Riveros MD; Thompson S; Pasik L; Mallagrino H; Celeste F; Casabé AR
Cancer; 2003 Jul; 98(2):262-8. PubMed ID: 12872343
[TBL] [Abstract][Full Text] [Related]
8. Differences in shotgun protein expression profile between superficial bladder transitional cell carcinoma and normal urothelium.
Niu HT; Zhang YB; Jiang HP; Cheng B; Sun G; Wang Y; E YJ; Pang de Q; Chang JW
Urol Oncol; 2009; 27(4):400-6. PubMed ID: 18818109
[TBL] [Abstract][Full Text] [Related]
9. The immunohistochemical detection of cripto-1 in benign and malignant human bladder.
Byrne RL; Autzen P; Birch P; Robinson MC; Gullick WJ; Neal DE; Hamdy FC
J Pathol; 1998 May; 185(1):108-11. PubMed ID: 9713367
[TBL] [Abstract][Full Text] [Related]
10. Searching urinary tumor markers for bladder cancer using a two-dimensional differential gel electrophoresis (2D-DIGE) approach.
Orenes-Piñero E; Cortón M; González-Peramato P; Algaba F; Casal I; Serrano A; Sánchez-Carbayo M
J Proteome Res; 2007 Nov; 6(11):4440-8. PubMed ID: 17902641
[TBL] [Abstract][Full Text] [Related]
11. Loss expression of uroplakin III is associated with clinicopathologic features of aggressive bladder cancer.
Matsumoto K; Satoh T; Irie A; Ishii J; Kuwao S; Iwamura M; Baba S
Urology; 2008 Aug; 72(2):444-9. PubMed ID: 18313120
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis of protein expression in human tonsillar cancer: differentially expressed proteins characterize human tonsillar cancer.
Roblick UJ; Bader FG; Hammarstedt L; Habermann JK; Hellman U; Becker S; Sundmacker A; Gemoll T; Zimmermann K; Auer G; Munck-Wikland E
Acta Oncol; 2008; 47(8):1493-501. PubMed ID: 18759147
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of annexin a1 induced by terephthalic acid calculi in rat bladder cancer.
Cui L; Wang Y; Shi Y; Zhang Z; Xia Y; Sun H; Wang S; Chen J; Zhang W; Lu Q; Song L; Wei Q; Zhang R; Wang X
Proteomics; 2007 Nov; 7(22):4192-202. PubMed ID: 17994624
[TBL] [Abstract][Full Text] [Related]
14. Molecular alterations associated with bladder cancer initiation and progression.
Cordon-Cardo C
Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
[TBL] [Abstract][Full Text] [Related]
15. Proteomics and immunohistochemistry define some of the steps involved in the squamous differentiation of the bladder transitional epithelium: a novel strategy for identifying metaplastic lesions.
Celis JE; Celis P; Ostergaard M; Basse B; Lauridsen JB; Ratz G; Rasmussen HH; Orntoft TF; Hein B; Wolf H; Celis A
Cancer Res; 1999 Jun; 59(12):3003-9. PubMed ID: 10383167
[TBL] [Abstract][Full Text] [Related]
16. Association of cyclin D1 and E1 expression with disease progression and biomarkers in patients with nonmuscle-invasive urothelial cell carcinoma of the bladder.
Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y
Urol Oncol; 2007; 25(6):468-75. PubMed ID: 18047954
[TBL] [Abstract][Full Text] [Related]
17. Identification of S100A8 and S100A9 as serological markers for colorectal cancer.
Kim HJ; Kang HJ; Lee H; Lee ST; Yu MH; Kim H; Lee C
J Proteome Res; 2009 Mar; 8(3):1368-79. PubMed ID: 19186948
[TBL] [Abstract][Full Text] [Related]
18. Searching cell-secreted proteomes for potential urinary bladder tumor markers.
Lin CY; Tsui KH; Yu CC; Yeh CW; Chang PL; Yung BY
Proteomics; 2006 Aug; 6(15):4381-9. PubMed ID: 16819731
[TBL] [Abstract][Full Text] [Related]
19. Redox- and expression-proteomic analysis of plasma biomarkers in bladder transitional cell carcinoma.
Lee YR; Chen YW; Tsai MC; Chou HC; Chan HL
Mol Biosyst; 2012 Oct; 8(12):3314-24. PubMed ID: 23090237
[TBL] [Abstract][Full Text] [Related]
20. Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.
Karam JA; Shariat SF; Huang HY; Pong RC; Ashfaq R; Shapiro E; Lotan Y; Sagalowsky AI; Wu XR; Hsieh JT
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4400-6. PubMed ID: 17671122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
